SBIA
APYX icon

Sheaff Brock Investment Advisors’s Apyx Medical APYX Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,500
Closed -$66K – 496
2019
Q1 		$66K Buy
+10,500
New +$81.2K 0.01% 489

Other funds holding APYX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Horizon Kinetics Asset Management
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sheaff Brock Investment Advisors's APYX Position: Q2 2019 in Review

Sheaff Brock Investment Advisors sold out of Apyx Medical (APYX) in Q2 2019, closing a stake of 10,500 shares — an estimated $66K sold.

Sheaff Brock Investment Advisors first reported a position in APYX in Q1 2019 and held it in 1 quarter. The position peaked at $66K in Q1 2019. 66 funds tracked by Wall St. Rank hold APYX as of Q2 2019.

  • Sheaff Brock Investment Advisors reported no remaining Apyx Medical position as of Q2 2019 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 10,500 Apyx Medical shares in Q2 2019, an estimated $66K.
  • Sheaff Brock Investment Advisors first reported a position in Apyx Medical in Q1 2019 and held it in 1 quarter.
  • Sheaff Brock Investment Advisors's Apyx Medical position peaked at $66K in Q1 2019.
  • 66 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2019.

Based on Sheaff Brock Investment Advisors's 13F filing for Q2 2019, filed 31 Jul 2019.